scroll to top
0
Press enter or spacebar to select a desired language.
Press enter or spacebar to select a desired language.
Your source for trusted research content

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "Mirandola, Massimo"

1 - 10 of 201 results for
 "Mirandola, Massimo"
Press enter or spacebar to adjust the number of results displayed.

Colonisation with Extended-Spectrum Cephalosporin-Resistant Enterobacterales and Infection Risk in Surgical Patients: A Systematic Review and Meta-analysis

Publication Type: Academic Journal

Source(s): Infectious Diseases and Therapy, Vol 12, Iss 2, Pp 623-636 (2023)

Abstract: Abstract Introduction Limited evidence has been reported for surgical site infections (SSIs) in patients undergoing surgery who are carriers of extended-spectrum cephalosporin-resistant Enterobacterales (ESCR-E). A systematic review and meta-analysis w...

Mycoplasma genitalium antibiotic resistance-associated mutations in genital and extragenital samples from men-who-have-sex-with-men attending a STI clinic in Verona, Italy

Publication Type: Academic Journal

Source(s): Frontiers in Cellular and Infection Microbiology, Vol 13 (2023)

Abstract: BackgroundMycoplasma genitalium (MG) is one of the most warning emerging sexually transmitted pathogens also due to its ability in developing resistance to antibiotics. MG causes different conditions ranging from asymptomatic infections to acute mucous...

Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern

Publication Type: Academic Journal

Source(s): eLife, Vol 11 (2022)

Abstract: Background: Recent in-vitro data have shown that the activity of monoclonal antibodies (mAbs) targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) varies according to the variant of concern (VOC). No studies have compared the clinical...

Harmonization and standardization of data for a pan-European cohort on SARS- CoV-2 pandemic

Publication Type: Academic Journal

Source(s): npj Digital Medicine, Vol 5, Iss 1, Pp 1-13 (2022)

Abstract: Abstract The European project ORCHESTRA intends to create a new pan-European cohort to rapidly advance the knowledge of the effects and treatment of COVID-19. Establishing processes that facilitate the merging of heterogeneous clusters of retrospective...

What is the empirical basis for converting banded ordinal data on numbers of sex partners among MSM into a continuous scale level variable? A secondary analysis of 13 surveys across 17 countries

Publication Type: Academic Journal

Source(s): BMC Medical Research Methodology, Vol 22, Iss 1, Pp 1-7 (2022)

Abstract: Abstract Background To provide empirically based guidance for substituting partner number categories in large MSM surveys with mean numbers of sexual and condomless anal intercourse (CAI) partners in a secondary analysis of survey data. Methods We coll...

Impact of COVID-19 and Antibiotic Treatments on Gut Microbiome: A Role for Enterococcus spp.

Publication Type: Academic Journal

Source(s): Biomedicines, Vol 10, Iss 2786, p 2786 (2022)

Abstract: Objective: Several studies showed the substantial use of antibiotics and increased risk of antimicrobial resistant infections in patients with COVID-19. The impact of COVID-19-related treatments and antibiotics on gut dysbiosis has not been clarified. ...

Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern.

Publication Type: Academic Journal

Source(s): eLife. 11/22/2022, p1-17. 17p.

Abstract: Background: Recent in-vitro data have shown that the activity of monoclonal antibodies (mAbs) targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) varies according to the variant of concern (VOC). No studies have compared the clinical...

Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study

Publication Type: Academic Journal

Source(s): Biomedicines, Vol 10, Iss 2063, p 2063 (2022)

Abstract: The clinical impact of anti-spike monoclonal antibodies (mAb) in Coronavirus Disease 2019 (COVID-19) breakthrough infections is unclear. We present the results of an observational prospective cohort study assessing and comparing COVID-19 progression in...

sponsored